News Article

Cancer Genetics Inc., a Rutherford, N.J.-based cancer diagnostics company, has postponed its $50 million IPO
Date: Jan 01, 2012

Featured firm in this article: Cancer Genetics Inc of Rutherford, NJ

The company had planned to begin trading this week on the Nasdaq under ticker symbol CGIX, with William Blair & Co. and Baird serving as co-lead underwriters. It reports around a $16 million net loss on over $2 million in revenue for the first nine months of 2011.